Rottinghaus Scott T. - Insider Non-Derivative Transactions at ENANTA PHARMACEUTICALS INC (ENTA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 5, 2025, Rottinghaus Scott T.'s relationship to ENANTA PHARMACEUTICALS INC (ENTA) is Officer (Chief Medical Officer), and currently has 21,792 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ENTA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Rottinghaus Scott T. - Insider Non-Derivative Transactions of ENTA Common Stock

Rottinghaus Scott T. - Insider Non-Derivative Transactions at ENTA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 6, 2025	Sell -- (Common Stock)	798	14.23	21792
Aug 9, 2025	F -- (Common Stock)	2217	6.99	22590
Feb 13, 2025	F -- (Common Stock)	2861	5.59	24807
Feb 13, 2025	Acquisition -- (Common Stock)	9750	0	27668
Dec 7, 2024	Sell -- (Common Stock)	866	8.06	17918
Aug 9, 2024	F -- (Common Stock)	1466	12.73	18784
Jul 16, 2024	Sell -- (Common Stock)	5375	17.08	21717
Jul 16, 2024	M -- (Common Stock)	5375	8.99	27092
Jul 13, 2024	Sell -- (Common Stock)	2271	15.04	21717
Jul 12, 2024	Sell -- (Common Stock)	4299	15.07	23988
Feb 13, 2024	F -- (Common Stock)	755	12.41	28287
Feb 13, 2024	Acquisition -- (Common Stock)	2576	0	29042
Dec 6, 2023	Sell -- (Common Stock)	534	9.63	26466
Aug 9, 2023	F -- (Common Stock)	1467	17.23	25533